Activin and Inhibin

CMPD-39 is a selective USP30 inhibitor with an IC 50 of 0.02 μM. CMPD-39 increases protein ubiquitination and accelerates mitophagyForm:SolidIC50&amp: Target:USP30 0.02 μM (IC 50 ).

CMPD-39 is a selective USP30 inhibitor with an IC 50 of 0.02 μM. CMPD-39 increases protein ubiquitination and accelerates mitophagyForm:SolidIC50&amp: Target:USP30 0.02 μM (IC 50 ).

CMPD-39 is a selective USP30 inhibitor with an IC 50 of 0.02 μM. CMPD-39 increases protein ubiquitination and accelerates mitophagyIC50&amp: Target:USP30 0.02 μM (IC 50 ).

CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC 50 values of 7 nM and 200 nM, respectively. CMS-121 has strong

CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC 50 values of 7 nM and 200 nM, respectively. CMS-121 has strong

CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC 50 values of 7 nM and 200 nM, respectively. CMS-121 has strong

CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC 50 values of 7 nM and 200 nM, respectively. CMS-121 has strong

CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC 50 values of 7 nM and 200 nM, respectively. CMS-121 has strong

CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC 50 values of 7 nM and 200 nM, respectively. CMS-121 has strong

CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC 50 values of 7 nM and 200 nM, respectively. CMS-121 has strong

CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor with IC 50 of 6.8 nM.In VitroCNX-1351 is able to potently (EC 50 &lt:100 nM) and specifically inhibit signaling in PI3Kα-dependent cancer cell lines, and this leads to a

CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor with IC 50 of 6.8 nM.In VitroCNX-1351 is able to potently (EC 50 &lt:100 nM) and specifically inhibit signaling in PI3Kα-dependent cancer cell lines, and this leads to a